Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elenge DM"'
Autor:
Elenge DM; GSK, Wavre, Belgium., Heo JS; Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea., Kim SS; Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea., Kim YK; Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea., Lee JH; Department of Pediatrics, Ajou University School of Medicine, Suwon, South Korea., Xavier S; GSK, Bangalore, India., Bahar E; GSK, Wavre, Belgium., Dos Santos G; GSK, Wavre, Belgium., Guignard A; GSK, Wavre, Belgium.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2406060. Date of Electronic Publication: 2024 Oct 08.
Autor:
Mendoza YG; GSK, Wavre, Belgium., Jusot V; GSK, Wavre, Belgium. viviane.x.jusot@gsk.com., Adou F; Autorité Ivoirienne de Régulation Pharmaceutique (AIRP), Abidjan, Ivory Coast., Ota M; GSK, Wavre, Belgium., Elenge DM; GSK, Wavre, Belgium., Begum T; GSK Consumer Healthcare, Warren, NJ, USA., Mdladla N; ViiV Healthcare, Johannesburg, South Africa., Menang O; PATH, Geneva, Switzerland., Yavo JC; Autorité Ivoirienne de Régulation Pharmaceutique (AIRP), Abidjan, Ivory Coast., Kamagaté M; Service de pharmacologie clinique, UFR-sciences médicales Bouaké, université Alassane-Ouattara, Abidjan, Ivory Coast.
Publikováno v:
Drug safety [Drug Saf] 2024 Feb; Vol. 47 (2), pp. 147-159. Date of Electronic Publication: 2023 Nov 15.